Found: 25
Select item for more details and to access through your institution.
De‐risking Clinical Trials: The BIAL Phase I Trial in Foresight.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 362, doi. 10.1002/cpt.2498
- By:
- Publication type:
- Article
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 341, doi. 10.1002/cpt.2497
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 346, doi. 10.1002/cpt.2496
- Publication type:
- Article
BIA 10‐2474: Some Lessons are Clear but Important Questions Remain Unanswered.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 343, doi. 10.1002/cpt.2495
- By:
- Publication type:
- Article
ACPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 348, doi. 10.1002/cpt.2494
- Publication type:
- Article
Physiologically‐Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 496, doi. 10.1002/cpt.2458
- By:
- Publication type:
- Article
Determining the Exposure Threshold for Levonorgestrel Efficacy Using an Integrated Model Based Meta‐Analysis Approach.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 509, doi. 10.1002/cpt.2457
- By:
- Publication type:
- Article
Exposure–Response Analyses of Letermovir Following Oral and Intravenous Administration in Allogeneic Hematopoietic Cell Transplantation Recipients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 485, doi. 10.1002/cpt.2456
- By:
- Publication type:
- Article
Effects of the Moderate CYP3A4 Inhibitor Erythromycin on the Pharmacokinetics of Palbociclib: A Randomized Crossover Trial in Patients With Breast Cancer.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 477, doi. 10.1002/cpt.2455
- By:
- Publication type:
- Article
A Proposed Approach for the Determination of the Bioequivalence Acceptance Range for Narrow Therapeutic Index Drugs in the European Union.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 470, doi. 10.1002/cpt.2451
- By:
- Publication type:
- Article
CYP2C19 Loss‐of‐function Polymorphisms are Associated with Reduced Risk of Sulfonylurea Treatment Failure in Chinese Patients with Type 2 Diabetes.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 461, doi. 10.1002/cpt.2446
- By:
- Publication type:
- Article
Effect of the Proton Pump Inhibitor Esomeprazole on the Systemic Exposure of Capecitabine: Results of A Randomized Crossover Trial.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 455, doi. 10.1002/cpt.2444
- By:
- Publication type:
- Article
Real‐world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research Pilot.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 444, doi. 10.1002/cpt.2443
- By:
- Publication type:
- Article
Compatibility of FIASMA Pharmacokinetics With Study End Points?
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 353, doi. 10.1002/cpt.2442
- By:
- Publication type:
- Article
Identifying Potential Therapeutic Applications and Diagnostic Harms of Increased Bilirubin Concentrations: A Clinical and Genetic Approach.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 435, doi. 10.1002/cpt.2441
- By:
- Publication type:
- Article
Leveraging Human Plasma‐Derived Small Extracellular Vesicles as Liquid Biopsy to Study the Induction of Cytochrome P450 3A4 by Modafinil.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 425, doi. 10.1002/cpt.2440
- By:
- Publication type:
- Article
Semi‐Mechanistic PK/PD Modeling and Simulation of Irreversible BTK Inhibition to Support Dose Selection of Tirabrutinib in Subjects with RA.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 416, doi. 10.1002/cpt.2439
- By:
- Publication type:
- Article
Biomarker‐Informed Model‐Based Risk Assessment of Organic Anion Transporting Polypeptide 1B Mediated Drug‐Drug Interactions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 404, doi. 10.1002/cpt.2434
- By:
- Publication type:
- Article
Clinical Pharmacogenetics Implementation Consortium Guideline for the Use of Aminoglycosides Based on MT‐RNR1 Genotype.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 366, doi. 10.1002/cpt.2309
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 333, doi. 10.1002/cpt.2293
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10‐2474: A Double‐Blind, Randomized, Placebo‐Controlled Study in Healthy Volunteers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 391, doi. 10.1002/cpt.2290
- By:
- Publication type:
- Article
The PMDA Perspectives on New Oral Prolyl Hydroxylase Domain Enzyme Inhibitors for Renal Anemia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 358, doi. 10.1002/cpt.2275
- By:
- Publication type:
- Article
Essential (and Largely Untaught) Skills for Clinical Pharmacology in Oncology Drug Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 354, doi. 10.1002/cpt.2264
- By:
- Publication type:
- Article
Oncofertility Information Available for Recently Approved Novel Non Cytotoxic and Immunotherapy Oncology Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 382, doi. 10.1002/cpt.2254
- By:
- Publication type:
- Article
Perspectives on Virtual (Remote) Clinical Trials as the "New Normal" to Accelerate Drug Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 2, p. 373, doi. 10.1002/cpt.2248
- By:
- Publication type:
- Article